Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
South Med J ; 101(12): 1209-15, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19005426

RESUMEN

OBJECTIVES: The number and types of inpatients given inadequate prophylaxis for venous thromboembolism (VTE) are not known; patients receive less than appropriate prophylaxis with some frequency. METHODS: Initially we evaluated VTE prophylaxis at a community hospital by comparing prophylaxis patterns in adult inpatients for whom some prophylaxis was indicated. Patients were categorized as medical, general surgery, and orthopedic, then categorized as "appropriate," "suboptimal," or "none" in terms of VTE prophylaxis. After initial data collection, we performed an intervention on medical patients using a VTE risk assessment tool; a printed evaluation containing the VTE risk assessment score with related VTE prophylaxis regimens was placed in the patients' charts, after which prophylaxis patterns were compared between preintervention and postintervention medical patients. RESULTS: Initial data collected from 116 medical, 110 general surgery, and 72 orthopedic patients (n = 298) showed that there was a significant association between diagnosis category and level of observed appropriate VTE prophylaxis (P < 0.0001). Fifty-six medical patients (48%) received no prophylaxis, compared to 40 (36%) general surgery patients and 12 (17%) orthopedic patients. In the second phase, 74 medical patients on whom the intervention was performed were compared to 116 preintervention medical patients (n = 190). The findings showed that intervention status had a significant association with level of appropriate VTE prophylaxis (P < 0.0001). CONCLUSION: An increase in appropriate VTE prophylaxis was observed after a system-level intervention.


Asunto(s)
Hospitalización , Garantía de la Calidad de Atención de Salud , Tromboembolia Venosa/prevención & control , Adulto , Anciano , Anciano de 80 o más Años , Anticoagulantes/administración & dosificación , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Enoxaparina/administración & dosificación , Femenino , Adhesión a Directriz , Heparina/administración & dosificación , Hospitales Comunitarios , Humanos , Inyecciones Subcutáneas , Aparatos de Compresión Neumática Intermitente , Masculino , Persona de Mediana Edad , Guías de Práctica Clínica como Asunto , Indicadores de Calidad de la Atención de Salud , Medición de Riesgo , Medias de Compresión , Resultado del Tratamiento , Tromboembolia Venosa/etiología , Warfarina/administración & dosificación
2.
J Am Assoc Nurse Pract ; 30(11): 630-637, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-30383549

RESUMEN

BACKGROUND AND PURPOSE: Migraine headache is an enormous health care burden resulting in billions of dollars in workforce revenue lost and millions of lost workdays per year. Migraine headaches and depression are common comorbidities and require expertise in treatment and prevention. METHODS: The aim of this article is to update the nurse practitioner (NP) on best clinical practices for managing the patient with migraine and previously diagnosed depression. This will include an overview of the pathophysiology of migraine, as well as criteria for diagnosis, treatment, prevention, and patient teaching. CONCLUSIONS: Migraine and depression are commonly linked and require expertise in treatment to achieve the best patient outcomes. IMPLICATIONS FOR PRACTICE: Patients with migraine are more likely to have depression than the general population. Both conditions require optimal treatment and patient education to reduce overall disease burden. A better understanding of the relationship between depression and migraine will enable the NP to better manage patients with migraine and comorbid depression.


Asunto(s)
Depresión/complicaciones , Trastornos Migrañosos/diagnóstico , Trastornos Migrañosos/tratamiento farmacológico , Guías de Práctica Clínica como Asunto , Comorbilidad , Depresión/psicología , Dihidroergotamina/efectos adversos , Dihidroergotamina/farmacología , Dihidroergotamina/uso terapéutico , Manejo de la Enfermedad , Humanos , Trastornos Migrañosos/psicología , Agonistas del Receptor de Serotonina 5-HT1/efectos adversos , Agonistas del Receptor de Serotonina 5-HT1/farmacología , Agonistas del Receptor de Serotonina 5-HT1/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA